BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7910951)

  • 1. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
    Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAEM case report #29: Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    Muscle Nerve; 1995 Sep; 18(9):937-42. PubMed ID: 7643872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle weakness in mechanically ventilated patients with severe asthma.
    Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
    Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent paralysis after prolonged use of atracurium in the absence of corticosteroids.
    Rubio ER; Seelig CB
    South Med J; 1996 Jun; 89(6):624-6. PubMed ID: 8638206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged neuromuscular damage following corticosteroids and muscle relaxants].
    Sharabi Y; Segal E; Grossman E
    Harefuah; 2000 Jun; 138(12):1030-2, 1087, 1086. PubMed ID: 10979426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
    Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K
    Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
    Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    Buck ML; Reed MD
    Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute necrotizing myopathy of intensive care: electrophysiological studies.
    Zochodne DW; Ramsay DA; Saly V; Shelley S; Moffatt S
    Muscle Nerve; 1994 Mar; 17(3):285-92. PubMed ID: 7906383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiratory muscle weakness after prolonged use of hydrocortisone and pancuronium bromide].
    Koishi K; Ooe Y; Hirata A; Kimura H; Izawa M
    Masui; 2000 Jan; 49(1):72-4. PubMed ID: 10689850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged paralysis after neuromuscular junction blockade: case reports and electrodiagnostic findings.
    Gooch JL; Moore MH; Ryser DK
    Arch Phys Med Rehabil; 1993 Sep; 74(9):1007-11. PubMed ID: 8379831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vecuronium induced prolonged paralysis in two pediatric intensive care patients.
    Kendirli T; Incesoy S; Ince E; Tutar E
    Can J Neurol Sci; 2005 Feb; 32(1):130-1. PubMed ID: 15825561
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    J Toxicol Clin Toxicol; 1995; 33(5):419-26. PubMed ID: 7650766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paralysis after long-term administration of neuromuscular blocking agents].
    Sugai N
    Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.